| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | Chief Business Officer | American Depositary Shares | 1,000 | $62,460 | $62.46 | 07 Feb 2023 | Direct |
| Terns Pharmaceuticals, Inc. | Chief Business Officer | Common Stock | 2,250 | $11,498 | $5.11 | 30 Nov 2024 | Direct |
| Terns Pharmaceuticals, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 325,000 | 30 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 30 Jan 2025 | 2 | +$11,498 | 4 | Chief Business Officer | 03 Feb 2025, 19:28 |
| TERN | Terns Pharmaceuticals, Inc. | 01 May 2024 | 1 | $0 | 4 | Chief Business Officer | 02 May 2024, 17:29 |
| TERN | Terns Pharmaceuticals, Inc. | 22 Apr 2024 | 0 | $0 | 3 | Chief Business Officer | 02 May 2024, 17:24 |
| GPCR | Structure Therapeutics Inc. | 07 Feb 2023 | 1 | +$15,000 | 4 | Chief Business Officer | 09 Feb 2023, 18:06 |
| GPCR | Structure Therapeutics Inc. | 02 Feb 2023 | 0 | $0 | 3 | Chief Business Officer | 02 Feb 2023, 17:19 |